NP49024 Growth Hormone
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £451K-£15M
- Sector
- HEALTH
- Published
- 13 Jan 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
1 buyer
- NHS National Services Scotland NSS Edinburgh
4 suppliers
- Merck Serono Middlesex
- Novo Nordisk Gatwick
- Pfizer Tadworth
- Sandoz Surrey
Description
This Framework Agreement is for the supply of Growth Hormone to health boards across NHS Scotland.
Lot Division
1 | Growth Hormone Daily Dose Supply of Growth Hormone (daily dose) to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework. |
2 | Growth Hormone Long-Acting Supply of Growth Hormone (Long Acting) to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per product line. |
Award Detail
1 | Merck Serono (Middlesex)
|
2 | Novo Nordisk (Gatwick)
|
3 | Pfizer (Tadworth)
|
4 | Sandoz (Surrey)
|
5 | Novo Nordisk (Gatwick)
|
6 | Pfizer (Tadworth)
|
Award Criteria
Storage Conditions | 4 |
Homecare | 4 |
Ancillaries | 4 |
Indications | 4 |
Waste Reduction | 4 |
price | 80 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.5 [and within all Lots] cover(s) the thirty six month contract duration and the 12 month extension period of the framework agreement. (SC Ref:784209)
Reference
- ocds-h6vhtk-049ab4
- FTS 000987-2025